Pediatric Ward A, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
Primary Immunodeficiency Clinic, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
Clin Exp Immunol. 2020 Sep;201(3):297-305. doi: 10.1111/cei.13474. Epub 2020 Jul 13.
Modern era advancements in medical care, with improved treatment of infections, can result in delayed diagnosis of congenital immunodeficiencies. In this study we present a retrospective cohort of 16 patients diagnosed with Chronic Granulomatous Disease (CGD) at adulthood. Some of the patients had a milder clinical phenotype, but others had a classic phenotype with severe infectious and inflammatory complications reflecting a profoundly impaired neutrophil function. It is therefore of great importance to investigate the individual journey of each patient through different misdiagnoses and the threads which led to the correct diagnosis. Currently the recommended definitive treatment for CGD is hematopoietic stem cell transplantation (HSCT). Although survival of our patients to adulthood might argue against the need for early HSCT during infancy, we claim that the opposite is correct, as most of them grew to be severely ill and diagnosed at a stage when HSCT is debatable with potentially an unfavorable outcome. This cohort stresses the need to increase awareness of this severe congenital immunodeficiency among clinicians of different specialties who might be treating undiagnosed adult patients with CGD.
现代医疗保健的进步,加上感染治疗的改善,可能导致先天性免疫缺陷的诊断延迟。在这项研究中,我们回顾性分析了 16 名成年后被诊断为慢性肉芽肿病(CGD)的患者。其中一些患者的临床表现较轻,但也有一些患者表现为典型的临床表现,伴有严重的感染和炎症并发症,反映出中性粒细胞功能严重受损。因此,研究每个患者通过不同误诊的个体历程以及导致正确诊断的线索非常重要。目前,CGD 的推荐确定性治疗方法是造血干细胞移植(HSCT)。尽管我们的患者成年后存活下来,可能表明在婴儿期不需要早期进行 HSCT,但我们认为相反的情况才是正确的,因为他们中的大多数人病情严重,在 HSCT 存在争议且可能预后不佳的阶段才被诊断出来。这一队列强调了需要提高不同专科临床医生对这种严重先天性免疫缺陷的认识,他们可能正在治疗未确诊的 CGD 成年患者。